Breaking News from Estonia

from Bing and Google News
Estonia , Friday 05 June 2020

Estonia receives drug from Japan for participating in coronavirus study

Published on: Sunday 10 May 2020

Estonia receives drug from Japan for participating in coronavirus study Estonia became the first country in the world to receive the medicine Avigan, the active pharmaceutical ingredient of which is favipiravir, which can potentially be used in the treatment of the illness caused by the COVID-19 coronavirus. The drug is received as a trial, and Estonia, which is one of 80 countries requesting it from Japan, is obliged to share the results of the trial with the Japanese authorities.



Share this news on:  

RELATED NEWS